Clarity Capital Partners LLC reduced its stake in shares of Enovix Co. (NASDAQ:ENVX - Free Report) by 90.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,377 shares of the company's stock after selling 123,962 shares during the period. Clarity Capital Partners LLC's holdings in Enovix were worth $145,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Geode Capital Management LLC lifted its stake in shares of Enovix by 5.4% in the third quarter. Geode Capital Management LLC now owns 3,583,685 shares of the company's stock valued at $33,477,000 after buying an additional 182,757 shares during the period. Charles Schwab Investment Management Inc. boosted its holdings in shares of Enovix by 6.3% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,229,052 shares of the company's stock worth $11,479,000 after acquiring an additional 73,320 shares in the last quarter. Stifel Financial Corp grew its holdings in shares of Enovix by 6.2% during the third quarter. Stifel Financial Corp now owns 950,202 shares of the company's stock worth $8,875,000 after purchasing an additional 55,094 shares during the last quarter. Old West Investment Management LLC increased its position in Enovix by 12.3% in the 3rd quarter. Old West Investment Management LLC now owns 937,838 shares of the company's stock valued at $8,759,000 after acquiring an additional 102,452 shares in the last quarter. Finally, Fred Alger Management LLC raised its stake in shares of Enovix by 2,468.6% in the third quarter. Fred Alger Management LLC now owns 588,614 shares of the company's stock worth $5,498,000 after acquiring an additional 565,698 shares during the last quarter. Institutional investors and hedge funds own 50.92% of the company's stock.
Insider Buying and Selling at Enovix
In other news, Director Betsy S. Atkins sold 75,000 shares of the firm's stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $9.73, for a total value of $729,750.00. Following the completion of the transaction, the director now owns 99,497 shares in the company, valued at $968,105.81. This trade represents a 42.98 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 15.70% of the company's stock.
Enovix Stock Up 3.9 %
Shares of ENVX stock traded up $0.43 during trading on Friday, reaching $11.45. The company's stock had a trading volume of 4,233,087 shares, compared to its average volume of 5,691,960. Enovix Co. has a one year low of $5.70 and a one year high of $18.68. The business has a fifty day moving average price of $10.96 and a 200-day moving average price of $10.32. The company has a debt-to-equity ratio of 0.99, a quick ratio of 3.61 and a current ratio of 3.77.
Wall Street Analyst Weigh In
ENVX has been the subject of a number of research reports. Benchmark reissued a "buy" rating and issued a $25.00 price target on shares of Enovix in a report on Wednesday, October 30th. JPMorgan Chase & Co. lowered their target price on Enovix from $18.00 to $15.00 and set an "overweight" rating for the company in a research note on Tuesday, October 22nd. Janney Montgomery Scott lowered Enovix from a "buy" rating to a "neutral" rating and set a $10.00 price target on the stock. in a research note on Thursday, October 31st. Finally, Cantor Fitzgerald reissued an "overweight" rating and set a $30.00 price objective on shares of Enovix in a report on Wednesday, October 30th. Two analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Enovix presently has a consensus rating of "Moderate Buy" and a consensus target price of $20.50.
Read Our Latest Stock Report on ENVX
Enovix Profile
(
Free Report)
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Further Reading
Before you consider Enovix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.
While Enovix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
